Description
Indications
Description
Pharmacology
Dosage & Administration
- To prevent milk production (lactation): 1 mg Cabergoline tablet on the first day after delivery.
- To stop lactation once have started to breastfeed: 0.25 mg Cabergoline tablet every 12 hours for two days.
- To reduce prolactin levels in other conditions: Initially take one Cabergoline 0.5 mg tablet (to be taken in two doses) spread out over a week (e.g., half a tablet on Monday and the other half of the tablet on Thursday). Dose will be increased up to a maximum dose of 4.5 mg or until have responded fully to treatment.
-
Interaction
Medicines to lower blood pressure Medicines used to treat mental illness (e.g. antipsychotic medicines like
chlorpromazine, haloperidol) Medicines for nausea and vomiting (e.g. domperidone, Medicines for severe migraine headaches (e.g. pergolide, metoclopramide, bromocriptine, lisuride, ergotamine, dihydroergotamine, ergometrine or methysergide)Contraindications
History of serious mental disease, particularly psychotic disorders Liver or kidney disease High blood pressure in
pregnancy associated with swelling and protein in the urine (toxaemia of pregnancy) Antipsychotic or have a history of mental illness associated with child-birth (puerperal psychosis).Side Effects
Pregnant or planning to get pregnant, women must discuss with doctor before treatment though Caberol is pregnancy category B. Pregnant for at least one month, one should stop taking Caberol, as Caberol will stop producing milk. If someone plan to breastfeed should not take Caberol.Pregnancy & Lactation
Pregnant or planning to get pregnant, discuss this with doctor before treatment though the pregnancy category B. Before start using Cabergoline check that patient not pregnant. Pregnant for at least one month once have
stopped taking Cabergoline, As Ferticab will stop producing milk.If someone plan to breastfeed should not take Cabergoline.Precautions & Warnings
- Hypersensitive (allergic) to Caberol, to other medicines called ergot alkaloids, (e.g. pergolide, bromocriptine, lisuride, ergotamine or ergometrine) or to any of the other ingredients in the tablet
- Severe liver disease
- High blood pressure in pregnancy associated with swelling and protein in the urine (toxaemia of pregnancy)
- Anti-psychotics or have a history of mental illness associated with child-birth (puerperal psychosis)
- Pregnant or breastfeeding
- Treated with Caberol for a long period and have or had fibrotic reactions (scar tissue) affecting your heart
Dopamine agonists in general should not be used in patients with pregnancy induced hypertension, for example, pre-eclampsia and eclampsia, unless the potential benefit is judged to outweigh the possible risk. Initial doses higher than 1.0 mg may produce orthostatic hypotension. Care should be exercised when administering Caberol with other medications known to lower blood pressure. Caberol is not indicated for the inhibition or suppression of physiologic lactation. Use of bromocriptine, another dopamine agonist for this purpose, has been associated with cases of hypertension, stroke, and seizures. Since Caberol is extensively metabolized by the liver, caution should be used when administering Caberol to patients with hepatic impairment. Following diagnosis of pleural effusion or pulmonary fibrosis or valvulopathy, the discontinuance of Caberol has been reported to result in improvement of signs and symptoms.
Overdose Effects
Overdosage might be expected to produce nasal congestion, syncope or hallucinations. Measures to support blood pressure should be taken if necessary.





Reviews
There are no reviews yet.